Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.5%

3 terminated out of 26 trials

Success Rate

82.4%

-4.2% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

36%

5 of 14 completed with results

Key Signals

5 with results82% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (13)
P 1 (3)
P 2 (6)
P 3 (1)
P 4 (1)

Trial Status

Completed14
Recruiting5
Terminated3
Not Yet Recruiting2
Active Not Recruiting1
Unknown1

Trial Success Rate

82.4%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT03926299Not ApplicableCompleted

Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

NCT07450625Not ApplicableNot Yet RecruitingPrimary

Efficacy of Collagendep in Reducing Vulvar Dryness in Patients With Lichen Sclerosus Treated With Fat Grafting

NCT04967170Phase 1Active Not RecruitingPrimary

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

NCT07363733Not ApplicableRecruitingPrimary

Dynamic Quadripolar Radiofrequency VS Topical Corticosteroids in Women With Vulvar Lichen Sclerosus

NCT07352917Phase 2RecruitingPrimary

Methotrexate for Severe Vulvar Lichen Sclerosus

NCT07240519Not ApplicableRecruitingPrimary

To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.

NCT07240389Not ApplicableNot Yet RecruitingPrimary

Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy.

NCT06132919Phase 2CompletedPrimary

Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)

NCT05243563Phase 2TerminatedPrimary

Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?

NCT04951206Phase 4CompletedPrimary

Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus

NCT06360705Not ApplicableCompletedPrimary

StrataMGT for the Treatment of Vulvar Lichen Sclerosus

NCT06662942Phase 1RecruitingPrimary

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

NCT06661382Phase 1RecruitingPrimary

Use of Platelet Rich Plasma from Cord Blood Vs Placebo in the Treatment of Vulvar Lichen Sclerosus

NCT04134494Not ApplicableTerminatedPrimary

Laser Treatment for Vulvar Lichen Sclerosus

NCT05250466Not ApplicableUnknownPrimary

A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia

NCT04952961Not ApplicableCompleted

Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study

NCT05147129CompletedPrimary

Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus

NCT01126255Phase 2TerminatedPrimary

Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

NCT04148651Not ApplicableCompletedPrimary

The CO2RE® System for Vulvar Lichen Sclerosus

NCT05251220Completed

Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women

Scroll to load more

Research Network

Activity Timeline